Does berberine help weight loss? What the trials measured
Berberine trials measured body weight, body mass index (BMI) and waist circumference, often alongside blood sugar and blood fats; the two older individual trials discussed here enrolled people with diabetes or metabolic syndrome.[1][2][3] A 2020 review included 12 trials overall. In the five that measured body weight, the average difference against control was −2.07 kg, and NCCIH says more high-quality research is needed before firm conclusions.[1][4]
Three kinds of outcome, kept apart
| Outcome | What the evidence shows | Source |
|---|---|---|
| Body weight | −2.07 kg on average across 5 randomized trials that measured weight | Asbaghi 2020[1] |
| BMI | −0.47 kg/m² on average | Asbaghi 2020[1] |
| Waist circumference | −1.08 cm on average | Asbaghi 2020[1] |
| Liver enzymes (ALT, AST) | No significant change | Asbaghi 2020[1] |
| Body weight by dose and length | Effects mainly above 1 gram a day and beyond 8 weeks | 2022 review summarized by NCCIH[4] |
| Blood sugar | HbA1c fell from 9.5% to 7.5% in 3 months in adults with new type 2 diabetes; weight was not reported in the abstract | Yin 2008[2] |
Averages are differences against control groups in the pooled analysis; the 2008 figures are before-and-after values in the berberine group.[1][2]
Who was studied, and with what
- People with metabolic conditions. One 52-week trial enrolled 136 people with obesity, type 2 diabetes and metabolic syndrome.[3] The diabetes trial enrolled adults with new or poorly controlled diabetes.[2]
- A combination product. That 52-week trial tested berberine combined with milk thistle (Silybum marianum), so its improvements in waist size, abdominal fat measured by bioimpedance and blood markers describe the combination, not berberine alone.[3]
- Other measures in the same trials. The pooled analysis does not say in its abstract how diet or exercise advice differed between groups; that limits what the averages can show about berberine by itself.[1]
- Size of the change. The average of about 2 kg pools trials with different groups and doses.[1]
A larger, more recent trial
In a 2026 placebo-controlled trial, 337 adults with obesity and fatty liver disease but without diabetes received berberine 1 g a day or placebo for six months. Berberine did not produce greater weight loss: the difference between groups was 0.05 kg (95% CI −0.74 to 0.84). Visceral fat and liver fat, the main measures, also showed no significant benefit.[5] These results describe that group and do not cover every condition.[5]
What it adds up to
NCCIH states that additional high-quality research would be needed to reach definite conclusions about whether berberine reduces weight and BMI.[4]
Before you use berberine
- Medicines. Berberine has been shown to interact with cyclosporine; see berberine and medicines in the berberine guide.[4] If you take diabetes medicines, discuss berberine with your clinician, since trials measured its effect on blood sugar.[2]
- Pregnancy, breastfeeding and infants. NCCIH states that berberine is likely to be unsafe for infants and may be unsafe during pregnancy or breastfeeding.[4]
- Digestive effects. In the diabetes trial, across the berberine monotherapy and add-on groups, 20 of 58 patients (34.5%) reported gastrointestinal adverse events; 14 patients needed a dose reduction because of these effects.[2]
Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.
More about berberine
Sources
- Asbaghi O et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: a systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN, 2020;38:43–49. https://doi.org/10.1016/j.clnesp.2020.04.010 ↩
- Yin J et al. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 2008;57:712–717. https://doi.org/10.1016/j.metabol.2008.01.013 ↩
- Guarino G et al. Bioimpedance analysis, metabolic effects and safety of the association Berberis aristata/Bilybum marianum: a 52-week double-blind, placebo-controlled study in obese patients with type 2 diabetes. J Biol Regul Homeost Agents, 2017;31:495–502. https://pubmed.ncbi.nlm.nih.gov/28685558/ ↩
- NCCIH. Berberine and Weight Loss: What You Need To Know. https://www.nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know ↩
- Lei et al. Berberine in adults with obesity and fatty liver disease (BRAVO), randomized placebo-controlled trial. JAMA Network Open, 2026. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2844037 ↩
You may quote, republish or translate this article under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/): credit "Verateca", link to this page and indicate changes, including translations. Quotes from NIH, FDA and other sources, label texts and prices are not covered by this license.